$HRTX HERON THERAPEUTICS, INC. /DE/ Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in HERON THERAPEUTICS, INC. /DE/.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in HERON THERAPEUTICS, INC. /DE/. Insider overview, share value development, latest insider transactions and email notifications about new events in HERON THERAPEUTICS, INC. /DE/ for free.

CIK Number: 0000818033
IRS Number: 942875566
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: HRTX
Company Address: 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO 92121
Phone number: 6503662626
Former name: ADVANCED POLYMER SYSTEMS INC /DE/, date of change: 1992-07-03
Former name: ADVANCED POLYMER SYSTEMS INC /DE/, date of change: 1992-07-03
Former name: AP PHARMA INC /DE/, date of change: 2001-05-11

Heron Therapeutics, Inc. is a biotechnology company, which develops pharmaceutical products for patients suffering from cancer. The company develops products by using its proprietary Biochronomer polymer based drug delivery technology. Its products include SUSTOL, Pipeline, Cinvanti and HTX-011. The company has additional clinical and preclinical-stage programs in the area of pain management, all of which utilize its bio erodible, injectable and implantable delivery systems. Heron Therapeutics was founded in February 1983 and is headquartered in Redwood City, CA.

Prev close: $13.35
Average Daily Volume: 994,703
Days Low: $12.95
Year Low: $12.21
Year High: $25.46

HERON THERAPEUTICS, INC. /DE/ Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
MANHARD KIMBERLYExecutive VP, Drug Development4946,595shares bought: 59,620 / shares sold: -59,620 HOLDNov 02 201814 days ago
Quart Barry DChief Executive Officer89,2751,191,821shares bought: 330,040 / shares sold: -300,000 BUYSep 14 20182 months ago
TANG KEVIN CDirector5,830,21577,833,370shares bought: 3,901,324 / shares sold: -2,938,639 BUYSep 12 20182 months ago

View all HERON THERAPEUTICS, INC. /DE/ insiders.

HERON THERAPEUTICS, INC. /DE/ Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Nov 02 2018HRTXHERON THERAPEUTICS ...MANHARD KIMBERLYExecutive VP, Drug ...SellS30.6249415,1250494 to 0 (-100.00 %)
Nov 02 2018HRTXHERON THERAPEUTICS ...MANHARD KIMBERLYExecutive VP, Drug ...BuyJ23.6049411,6564940 to 494
Oct 02 2018HRTXHERON THERAPEUTICS ...MANHARD KIMBERLYExecutive VP, Drug ...Option ExerciseM13.006,00078,00082,416
Oct 02 2018HRTXHERON THERAPEUTICS ...MANHARD KIMBERLYExecutive VP, Drug ...SellS32.076,000192,43306 K to 0 (-100.00 %)
Oct 02 2018HRTXHERON THERAPEUTICS ...MANHARD KIMBERLYExecutive VP, Drug ...BuyM13.006,00078,0006,0000 to 6 K
Sep 14 2018HRTXHERON THERAPEUTICS ...Quart Barry DChief Executive Off ...Option ExerciseM7.2019,675141,660710,601
Sep 14 2018HRTXHERON THERAPEUTICS ...Quart Barry DChief Executive Off ...BuyM7.2019,675141,66089,27569.6 K to 89.3 K (+28.27 %)
Sep 12 2018HRTXHERON THERAPEUTICS ...TANG KEVIN CDirectorSellS35.752,695,00096,346,2505,830,2158.5 M to 5.8 M (-31.61 %)
Jul 03 2018HRTXHERON THERAPEUTICS ...MANHARD KIMBERLYExecutive VP, Drug ...Option ExerciseM13.006,00078,00088,416
Jul 03 2018HRTXHERON THERAPEUTICS ...MANHARD KIMBERLYExecutive VP, Drug ...SellS38.851003,8850100 to 0 (-100.00 %)
Jul 03 2018HRTXHERON THERAPEUTICS ...MANHARD KIMBERLYExecutive VP, Drug ...SellS37.515,900221,2941006 K to 100 (-98.33 %)
Jul 03 2018HRTXHERON THERAPEUTICS ...MANHARD KIMBERLYExecutive VP, Drug ...BuyM13.006,00078,0006,0000 to 6 K
Jul 03 2018HRTXHERON THERAPEUTICS ...HOFFMAN ROBERTCFO & SVP, FinanceOption ExerciseM15.3030,000459,000100,000
Jul 03 2018HRTXHERON THERAPEUTICS ...HOFFMAN ROBERTCFO & SVP, FinanceSellS38.801,06041,1231,2802.3 K to 1.3 K (-45.30 %)
Jul 03 2018HRTXHERON THERAPEUTICS ...HOFFMAN ROBERTCFO & SVP, FinanceSellS38.1528,9401,104,1072,34031.3 K to 2.3 K (-92.52 %)

View all HERON THERAPEUTICS, INC. /DE/ insider transactions.